Catalyst Wire Dossier Catalyst Wire Dossier

ONCOFID-P-B

paclitaxel-hyaluronic acid · Fidia Farmaceutici s.p.a.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ONCOFID-P-B, covering 2020-12-10 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) [Phase 3]

See pricing